UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK

European journal of surgical oncology, 2017-05, Vol.43 (5), p.931-937

2017

Volltextzugriff (PDF)

Prediction of Margin Involvement and Local Recurrence After Skin-Sparing and Simple Mastectomy

European journal of surgical oncology, 2016-07, Vol.42 (7), p.935-941

2016

Volltextzugriff (PDF)

Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?

Cancer treatment reviews, 2012-10, Vol.38 (6), p.798-806

2012

Volltextzugriff (PDF)

A randomised pilot study comparing 13 G vacuum-assisted biopsy and conventional 14 G core needle biopsy of axillary lymph nodes in women with breast cancer

Clinical radiology, 2016-06, Vol.71 (6), p.551-557

2016

Volltextzugriff (PDF)

The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast

European journal of surgical oncology, 2014-03, Vol.40 (3), p.249-254

2014

Volltextzugriff (PDF)

PO-36 - Thrombin Inhibition Preoperatively (TIP) in early breast cancer, the first clinical trial of NOACs as an anti-cancer agent: trial methodology

Thrombosis research, 2016-04, Vol.140, p.S189-S190

2016

Volltextzugriff (PDF)

325 The Correlation of Multifocality with Lymph Node Status in Patients with Breast Carcinoma

European journal of cancer (1990), 2012-03, Vol.48, p.S138-S138

2012

Volltextzugriff (PDF)

PO-21 - Stromal fibroblasts in preinvasive breast cancer (ductal carcinoma in situ, DCIS) demonstrate a cancer-like procoagulant phenotypic switch that may facilitate invasion

Thrombosis research, 2016-04, Vol.140, p.S184-S184

2016

Volltextzugriff (PDF)

The procoagulant response to cancer surgery is increased in early breast cancer with poor prognosis phenotypes

Thrombosis research, 2012-04, Vol.129, p.S172-S173

2012

Volltextzugriff (PDF)

Letter to the Editor regarding manuscript entitled: Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Grabau D, Dihge L, Ferno M, Ingvar C, Ryden L. Eur J Surg Oncol . 2013 Jun; 39 (6):601–7

European journal of surgical oncology, 2013-11, Vol.39 (11), p.1294-1295

2013

Volltextzugriff (PDF)

Molecular phenotypes of DCIS predict overall and invasive recurrence

Annals of oncology, 2015-05, Vol.26 (5), p.1019-1025

2015

Volltextzugriff (PDF)

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

Annals of oncology, 2011-12, Vol.22 (12), p.2546-2555

2011

Volltextzugriff (PDF)

Erratum to “Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK” [Eur J Surg Oncol 43 (5) (2017) 931–937]

European journal of surgical oncology, 2018-01, Vol.44 (1), p.194-194

Bundred, N.J.

2018

Volltextzugriff (PDF)

PO-23 Chemotherapy-induced venous thromboembolism is not due to endothelial cell activation

Thrombosis research, 2010, Vol.125, p.S172-S172

2010

Volltextzugriff (PDF)

PO-71 Potential for new trial end point: success of functional mammosphere assay in Thrombin Inhibition Preoperatively (TIP) trial in early breast cancer

Thrombosis research, 2021-04, Vol.200, p.S56

2021

Volltextzugriff (PDF)

PO-29: Coagulation and circulating tumour cells as pharmacodynamic biomarkers of response to aromatase inhibitors in breast cancer

Thrombosis research, 2022-05, Vol.213, p.S24-S24

2022

Volltextzugriff (PDF)

Coagulation as a pharmacodynamic biomarker in breast cancer: Changes in tumour expression of extrinsic clotting factors in response to breast cancer treatment

Thrombosis research, 2018-04, Vol.164, p.S181-S182

2018

Volltextzugriff (PDF)

O-32 D-dimer as a marker for early progression in patients commencing neoadjuvant chemotherapy

European journal of cancer supplements, 2010-09, Vol.8 (6), p.12-12

2010

Volltextzugriff (PDF)

O-25 ER positive screen detected breast cancers (SDBC) do not require chemotherapy

European journal of cancer supplements, 2010-09, Vol.8 (6), p.9-10

2010

Volltextzugriff (PDF)

OC-09: Rivaroxaban compared to no treatment in early breast cancer patients (the TIP Trial): initial findings for a phase II preoperative window-of-opportunity randomised controlled trial

Thrombosis research, 2022-05, Vol.213, p.S5-S6

2022

Volltextzugriff (PDF)

Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients—Design and baseline data ‘LIBERATE’ trial

Breast (Edinburgh), 2007, Vol.16, p.182-189

2007

Volltextzugriff (PDF)

366 Chemotherapy-induced venous thromboembolism is not due to endothelial cell activation

European journal of cancer supplements, 2010, Vol.8 (3), p.164-164

2010

Volltextzugriff (PDF)

Prognostic and predictive factors in breast cancer

Cancer treatment reviews, 2001-06, Vol.27 (3), p.137-142

Bundred, N.J.

2001

Volltextzugriff (PDF)

O-27 Epithelial proliferation (Ki67) is prognostic in symptomatic but not screen detected breast cancers (SDBC)

European journal of cancer supplements, 2010-09, Vol.8 (6), p.10-10

2010

Volltextzugriff (PDF)

Update for: Thrombin Inhibition Preoperatively (TIP) in Early Breast Cancer, the first clinical trial of DOACs as an anti-cancer agent

Thrombosis research, 2018-04, Vol.164, p.S224-S225

2018

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(110)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Oncology
(29)
Humans
(28)
Female
(25)
Hematology, Oncology And Palliative Medicine
(19)
Middle Aged
(12)
Aged
(11)
Breast Cancer
(11)
Breast Neoplasms - Pathology
(11)
Adult
(10)
Obstetrics & Gynecology
(9)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Prognosis
(7)
Breast Neoplasms - Chemistry
(6)
Breast Neoplasms - Therapy
(6)
Gynecology. Andrology. Obstetrics
(6)
Mammary Gland Diseases
(6)
Surgery
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK

Prediction of Margin Involvement and Local Recurrence After Skin-Sparing and Simple Mastectomy

Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?

A randomised pilot study comparing 13 G vacuum-assisted biopsy and conventional 14 G core needle biopsy of axillary lymph nodes in women with breast cancer

The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast

PO-36 - Thrombin Inhibition Preoperatively (TIP) in early breast cancer, the first clinical trial of NOACs as an anti-cancer agent: trial methodology

325 The Correlation of Multifocality with Lymph Node Status in Patients with Breast Carcinoma

PO-21 - Stromal fibroblasts in preinvasive breast cancer (ductal carcinoma in situ, DCIS) demonstrate a cancer-like procoagulant phenotypic switch that may facilitate invasion

The procoagulant response to cancer surgery is increased in early breast cancer with poor prognosis phenotypes

Molecular phenotypes of DCIS predict overall and invasive recurrence

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

Erratum to “Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK” [Eur J Surg Oncol 43 (5) (2017) 931–937]

PO-23 Chemotherapy-induced venous thromboembolism is not due to endothelial cell activation

PO-71 Potential for new trial end point: success of functional mammosphere assay in Thrombin Inhibition Preoperatively (TIP) trial in early breast cancer

PO-29: Coagulation and circulating tumour cells as pharmacodynamic biomarkers of response to aromatase inhibitors in breast cancer

Coagulation as a pharmacodynamic biomarker in breast cancer: Changes in tumour expression of extrinsic clotting factors in response to breast cancer treatment

O-32 D-dimer as a marker for early progression in patients commencing neoadjuvant chemotherapy

O-25 ER positive screen detected breast cancers (SDBC) do not require chemotherapy

OC-09: Rivaroxaban compared to no treatment in early breast cancer patients (the TIP Trial): initial findings for a phase II preoperative window-of-opportunity randomised controlled trial

Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients—Design and baseline data ‘LIBERATE’ trial

366 Chemotherapy-induced venous thromboembolism is not due to endothelial cell activation

Prognostic and predictive factors in breast cancer

O-27 Epithelial proliferation (Ki67) is prognostic in symptomatic but not screen detected breast cancers (SDBC)

Update for: Thrombin Inhibition Preoperatively (TIP) in Early Breast Cancer, the first clinical trial of DOACs as an anti-cancer agent

Suchergebnisse filtern